World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Novartis Plans Restructuring
Keywords:
Tags:
Novartis CEO Dr Vasella will organize a restructuring designed to get rid of bueaucracy in Novartis operations. He has see more than six layers between senior management and the lower ranks in many situations inside Novartis. The goal is speedier decisionmaking. He will also look at the large expense of third party companies that oversee clinical trials.
Novartis is developing a whole new system for developing pharmaceutical treatments by putting medical science at the centre of things.
12/11/2007
Novartis' CEO Vasella, and Dr Fishman who heads the global research labs in Cambridge, Massachusetts, are redoing the way the company develops drugs and runs the company. Senior leaders are now medically trained scientists, and Novartis has shed much of the old marketing and sales staff. Drug discovery focusses on Dr. Fishman's approach to go after common molecular pathways and develop medicines for diseases that may be rare, but reveal the knowledge behind addressing all diseases that have that common underlying molecular pathway as the source of the diseases functioning.
Grouped Articles
Novartis Chairman Stresses Need for R&D Investment
Wall Street Journal 03/22/2014
Wall Street Journal 12/11/2007
Wall Street Journal 12/17/2007
BusinessWeek 05/08/2008
CEO Gambles on a Novartis Makeover
Wall Street Journal 05/20/2008
BusinessWeek 09/04/2008
Novartis restructuring.
12/11/2007
Grouped Articles
Splitting the Pill at Novartis Will Be Easier Said Than Done
Wall Street Journal 11/18/2013
Novartis Starts $5 Billion Share Buyback
Wall Street Journal 11/22/2013
Wall Street Journal 12/11/2007
Novartis to Focus on Influence Insurers Wield Over Doctors
Wall Street Journal 12/14/2007
CEO Gambles on a Novartis Makeover
Wall Street Journal 05/20/2008
Wall Street Journal 10/21/2008
Novartis.
05/23/2007
Grouped Articles
Novartis Weighs Impact Of Teva's Generic Drug
Wall Street Journal 05/23/2007
Wall Street Journal 12/11/2007
CEO Gambles on a Novartis Makeover
Wall Street Journal 05/20/2008
Wall Street Journal 10/21/2008
Novartis Acquires Rights to Heart Drug
Wall Street Journal 02/12/2009
FDA Approves a Novel Novartis Drug
Wall Street Journal 06/19/2009
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
